{"id":60882,"date":"2025-12-23T09:23:22","date_gmt":"2025-12-23T00:23:22","guid":{"rendered":"https:\/\/www.marketresearch.jp\/reports\/?p=60882"},"modified":"2026-09-25T17:22:37","modified_gmt":"2026-09-25T08:22:37","slug":"cardiovascular-health-products-market","status":"publish","type":"post","link":"https:\/\/www.marketresearch.jp\/reports\/cardiovascular-health-products-market\/","title":{"rendered":"\u4e16\u754c\u306e\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u88fd\u54c1\u30bf\u30a4\u30d7\u5225\uff08\u533b\u7642\u6a5f\u5668\u3001\u533b\u85ac\u54c1\u3001\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\uff08\u30af\u30ea\u30cb\u30c3\u30af\u3001\u75c5\u9662\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\uff09\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u3001\u7528\u9014\u5225 &#8211; \u4e16\u754c\u5e02\u5834\u4e88\u6e2c2025-2032\u5e74"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.jp\/reports\/wp-content\/uploads\/2025\/12\/cardiovascular-health-products-statistics.png\" alt=\"Market Statistics\" style=\"max-width:100%;\"><\/p>\n<p>\u4ee5\u4e0b\u306b\u3001\u3054\u6307\u5b9a\u306e\u300c\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u300d\u3068\u3044\u3046\u7528\u8a9e\u3092\u53b3\u5bc6\u306b\u4f7f\u7528\u3057\u3001&#8217;Basic TOC&#8217;\u3068&#8217;Segmentation Details&#8217;\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u4f5c\u6210\u3057\u305f\u8a73\u7d30\u306a\u76ee\u6b21\uff08TOC\uff09\u306e\u65e5\u672c\u8a9e\u8a33\u3092\u63d0\u793a\u3057\u307e\u3059\u3002<\/p>\n<p>&#8212;<\/p>\n<p>**\u76ee\u6b21 (Table of Contents)**<\/p>\n<p>**I. \u5e8f\u6587 (Preface)**<br \/>\n    *   \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3068\u30ab\u30d0\u30ec\u30c3\u30b8 (Market Segmentation &#038; Coverage)<br \/>\n    *   \u8abf\u67fb\u5bfe\u8c61\u671f\u9593 (Years Considered for the Study)<br \/>\n    *   \u901a\u8ca8 (Currency)<br \/>\n    *   \u8a00\u8a9e (Language)<br \/>\n    *   \u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc (Stakeholders)<\/p>\n<p>**II. \u8abf\u67fb\u65b9\u6cd5 (Research Methodology)**<\/p>\n<p>**III. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc (Executive Summary)**<\/p>\n<p>**IV. \u5e02\u5834\u6982\u8981 (Market Overview)**<\/p>\n<p>**V. \u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8 (Market Insights)**<br \/>\n    *   \u5fc3\u8840\u7ba1\u30a6\u30a7\u30eb\u30cd\u30b9\u7ba1\u7406\u306e\u305f\u3081\u306eAI\u7d71\u5408\u578b\u30d1\u30fc\u30bd\u30ca\u30e9\u30a4\u30ba\u30c9\u30c7\u30b8\u30bf\u30eb\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u30c7\u30d0\u30a4\u30b9\u306e\u63a1\u7528\u5897\u52a0 (Increasing adoption of personalized digital monitoring devices integrating AI for cardiovascular wellness management)<br \/>\n    *   \u5fc3\u81d3\u306e\u5065\u5eb7\u306b\u826f\u3044\u30d3\u30bf\u30df\u30f3\u3068\u690d\u7269\u30a8\u30ad\u30b9\u3092\u5f37\u5316\u3057\u305f\u6a5f\u80fd\u6027\u98f2\u6599\u88fd\u5264\u306e\u6025\u5897 (Surge in functional beverage formulations fortified with heart health vitamins and botanical extracts)<br \/>\n    *   \u30a6\u30a7\u30a2\u30e9\u30d6\u30eb\u6280\u8853\u3068\u9060\u9694\u533b\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u6d3b\u7528\u3057\u305f\u975e\u85ac\u7269\u6027\u5fc3\u4e0d\u5168\u7ba1\u7406\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u62e1\u5927 (Expansion of nonpharmaceutical heart failure management solutions leveraging wearable tech and telehealth platforms)<br \/>\n    *   \u5fc3\u8840\u7ba1\u708e\u75c7\u3092\u8efd\u6e1b\u3057\u3001\u8102\u8cea\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u306e\u30de\u30a4\u30af\u30ed\u30d0\u30a4\u30aa\u30fc\u30e0\u3092\u6a19\u7684\u3068\u3057\u305f\u30d7\u30ed\u30d0\u30a4\u30aa\u30c6\u30a3\u30af\u30b9\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u306e\u958b\u767a (Development of microbiome-targeted probiotic supplements to reduce cardiovascular inflammation and improve lipid profiles)<br \/>\n    *   \u9ad8\u8840\u5727\u304a\u3088\u3073\u30a2\u30c6\u30ed\u30fc\u30e0\u6027\u52d5\u8108\u786c\u5316\u75c7\u306e\u500b\u5225\u5316\u3055\u308c\u305f\u4e88\u9632\u306e\u305f\u3081\u306e\u30b2\u30ce\u30df\u30af\u30b9\u4e3b\u5c0e\u578b\u6804\u990a\u88dc\u52a9\u98df\u54c1\u3078\u306e\u6295\u8cc7\u5897\u52a0 (Growing investment in genomics-driven nutraceuticals for personalized prevention of hypertension and atherosclerosis)<\/p>\n<p>**VI. 2025\u5e74\u306e\u7c73\u56fd\u95a2\u7a0e\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff (Cumulative Impact of United States Tariffs 2025)**<\/p>\n<p>**VII. 2025\u5e74\u306e\u4eba\u5de5\u77e5\u80fd\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff (Cumulative Impact of Artificial Intelligence 2025)**<\/p>\n<p>**VIII. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u88fd\u54c1\u30bf\u30a4\u30d7\u5225 (Cardiovascular Health Products Market, by Product Type)**<br \/>\n    *   \u533b\u7642\u6a5f\u5668 (Medical Devices)<br \/>\n        *   \u8a3a\u65ad\u6a5f\u5668 (Diagnostic Devices)<br \/>\n            *   \u8840\u5727\u8a08 (Blood Pressure Monitors)<br \/>\n            *   \u5fc3\u81d3\u753b\u50cf\u8a3a\u65ad\u30b7\u30b9\u30c6\u30e0 (Cardiac Imaging Systems)<br \/>\n            *   \u30db\u30eb\u30bf\u30fc\u30e2\u30cb\u30bf\u30fc (Holter Monitors)<br \/>\n        *   \u6cbb\u7642\u6a5f\u5668 (Therapeutic Devices)<br \/>\n            *   \u9664\u7d30\u52d5\u5668 (Defibrillators)<br \/>\n            *   \u30da\u30fc\u30b9\u30e1\u30fc\u30ab\u30fc (Pacemakers)<br \/>\n            *   \u30b9\u30c6\u30f3\u30c8 (Stents)<br \/>\n    *   \u533b\u85ac\u54c1 (Medications)<br \/>\n        *   \u6297\u51dd\u56fa\u5264 (Anticoagulants)<br \/>\n        *   \u964d\u5727\u5264 (Antihypertensive Agents)<br \/>\n            *   ACE\u963b\u5bb3\u5264 (Ace Inhibitors)<br \/>\n            *   \u30d9\u30fc\u30bf\u906e\u65ad\u85ac (Beta Blockers)<br \/>\n            *   \u30ab\u30eb\u30b7\u30a6\u30e0\u30c1\u30e3\u30cd\u30eb\u906e\u65ad\u85ac (Calcium Channel Blockers)<br \/>\n        *   \u30b9\u30bf\u30c1\u30f3 (Statins)<br \/>\n        *   \u8840\u7ba1\u62e1\u5f35\u5264 (Vasodilators)<br \/>\n    *   \u30b5\u30d7\u30ea\u30e1\u30f3\u30c8 (Supplements)<br \/>\n        *   \u30b3\u30a8\u30f3\u30b6\u30a4\u30e0Q10 (Coenzyme Q10)<br \/>\n        *   \u30aa\u30e1\u30ac3 (Omega 3)<br \/>\n        *   \u690d\u7269\u30b9\u30c6\u30ed\u30fc\u30eb (Plant Sterols)<\/p>\n<p>**IX. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225 (Cardiovascular Health Products Market, by Distribution Channel)**<br \/>\n    *   \u30af\u30ea\u30cb\u30c3\u30af (Clinics)<br \/>\n    *   \u75c5\u9662\u85ac\u5c40 (Hospital Pharmacies)<br \/>\n    *   \u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40 (Online Pharmacies)<br \/>\n    *   \u5c0f\u58f2\u85ac\u5c40 (Retail Pharmacies)<\/p>\n<p>**X. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 (Cardiovascular Health Products Market, by End User)**<br \/>\n    *   \u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<br \/>\n    *   \u30af\u30ea\u30cb\u30c3\u30af (Clinics)<br \/>\n    *   \u5728\u5b85\u30b1\u30a2 (Home Care)<br \/>\n    *   \u75c5\u9662 (Hospitals)<\/p>\n<p>**XI. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u7528\u9014\u5225 (Cardiovascular Health Products Market, by Application)**<br \/>\n    *   \u30e2\u30cb\u30bf\u30ea\u30f3\u30b0 (Monitoring)<br \/>\n    *   \u4e88\u9632 (Prevention)<br \/>\n    *   \u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3 (Rehabilitation)<br \/>\n    *   \u6cbb\u7642 (Treatment)<\/p>\n<p>**XII. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u5730\u57df\u5225 (Cardiovascular Health Products Market, by Region)**<br \/>\n    *   \u7c73\u5dde (Americas)<br \/>\n        *   \u5317\u7c73 (North America)<br \/>\n        *   \u4e2d\u5357\u7c73 (Latin America)<br \/>\n    *   \u6b27\u5dde\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab (Europe, Middle East &#038; Africa)<br \/>\n        *   \u6b27\u5dde (Europe)<br \/>\n        *   \u4e2d\u6771 (Middle East)<br \/>\n        *   \u30a2\u30d5\u30ea\u30ab (Africa)<br \/>\n    *   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b (Asia-Pacific)<\/p>\n<p>**XIII. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u30b0\u30eb\u30fc\u30d7\u5225 (Cardiovascular Health Products Market, by Group)**<br \/>\n    *   ASEAN (ASEAN)<br \/>\n    *   GCC (GCC)<br \/>\n    *   \u6b27\u5dde\u9023\u5408 (European Union)<br \/>\n    *   BRICS (BRICS)<br \/>\n    *   G7 (G7)<br \/>\n    *   NATO (NATO)<\/p>\n<p>**XIV. \u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u5e02\u5834\uff1a\u56fd\u5225 (Cardiovascular Health Products Market, by Country)**<br \/>\n    *   \u7c73\u56fd (United States)<br \/>\n    *   \u30ab\u30ca\u30c0 (Canada)<br \/>\n    *   \u30e1\u30ad\u30b7\u30b3 (Mexico)<br \/>\n    *   \u30d6\u30e9\u30b8\u30eb (Brazil)<br \/>\n    *   \u82f1\u56fd (United Kingdom)<br \/>\n    *   \u30c9\u30a4\u30c4 (Germany)<br \/>\n    *   \u30d5\u30e9\u30f3\u30b9 (France)<br \/>\n    *   \u30ed\u30b7\u30a2 (Russia)<br \/>\n    *   \u30a4\u30bf\u30ea\u30a2 (Italy)<br \/>\n    *   \u30b9\u30da\u30a4\u30f3 (Spain)<br \/>\n    *   \u4e2d\u56fd (China)<br \/>\n    *   \u30a4\u30f3\u30c9 (India)<br \/>\n    *   \u65e5\u672c (Japan)<br \/>\n    *   \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2 (Australia)<br \/>\n    *   \u97d3\u56fd (South Korea)<\/p>\n<p>**XV. \u7af6\u4e89\u74b0\u5883 (Competitive Landscape)**<br \/>\n    *   \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u30012024\u5e74 (Market Share Analysis, 2024)<br \/>\n    *   FPNV\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u30012024\u5e74 (FPNV Positioning Matrix, 2024)<br \/>\n    *   \u7af6\u5408\u5206\u6790 (Competitive Analysis)<br \/>\n        *   \u30b8\u30e7\u30f3\u30bd\u30f3\u30fb\u30a8\u30f3\u30c9\u30fb\u30b8\u30e7\u30f3\u30bd\u30f3 (Johnson &#038; Johnson)<br \/>\n        *   \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9AG (Novartis AG)<br \/>\n        *   \u30d5\u30a1\u30a4\u30b6\u30fc\u682a\u5f0f\u4f1a\u793e (Pfizer Inc.)<br \/>\n        *   \u30b5\u30ce\u30d5\u30a3S.A. (Sanofi S.A.)<br \/>\n        *   \u30a2\u30b9\u30c8\u30e9\u30bc\u30cd\u30abPLC (AstraZeneca PLC)<br \/>\n        *   \u30e1\u30eb\u30af\u30fb\u30a2\u30f3\u30c9\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc\u30fb\u30a4\u30f3\u30af (Merck &#038; Co., Inc.)<br \/>\n        *   \u30a2\u30dc\u30c3\u30c8\u30fb\u30e9\u30dc\u30e9\u30c8\u30ea\u30fc\u30ba (Abbott Laboratories)<br \/>\n        *   \u30d6\u30ea\u30b9\u30c8\u30eb\u30fb\u30de\u30a4\u30e4\u30fc\u30ba \u30b9\u30af\u30a4\u30d6\u793e (Bristol-Myers Squibb Company)<br \/>\n        *   \u30e1\u30c9\u30c8\u30ed\u30cb\u30c3\u30afplc (Medtronic plc)<br \/>\n        *   \u30dc\u30b9\u30c8\u30f3\u30fb\u30b5\u30a4\u30a8\u30f3\u30c6\u30a3\u30d5\u30a3\u30c3\u30af\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3 (Boston Scientific Corporation)<\/p>\n<p>**\u56f3\u8868\u30ea\u30b9\u30c8 [\u5408\u8a08: 28] (List of Figures [Total: 28])**<\/p>\n<p>**\u8868\u30ea\u30b9\u30c8 [\u5408\u8a08: 837] (List of Tables [Total: 837])**<\/p>\n<p>&#8230;&#8230;&#8230;&#8230; (\u4ee5\u4e0b\u7701\u7565)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u73fe\u4ee3\u30d8\u30eb\u30b9\u30b1\u30a2\u306b\u304a\u3044\u3066\u3001\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u306f\u3001\u4e16\u754c\u7684\u306a\u4e3b\u8981\u306a\u6b7b\u56e0\u30fb\u7f79\u60a3\u539f\u56e0\u3067\u3042\u308b\u5fc3\u81d3\u75c5\u306e\u8ca0\u62c5\u5897\u5927\u306b\u5bfe\u51e6\u3059\u308b\u4e0a\u3067\u4e0d\u53ef\u6b20\u306a\u5b58\u5728\u3067\u3059\u3002\u9ad8\u9f62\u5316\u3068\u6162\u6027\u75be\u60a3\u306e\u6709\u75c5\u7387\u5897\u52a0\u3092\u80cc\u666f\u306b\u3001\u8a3a\u65ad\u7cbe\u5ea6\u306e\u5411\u4e0a\u3001\u6cbb\u7642\u4ecb\u5165\u306e\u5408\u7406\u5316\u3001\u81ea\u5df1\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u30c4\u30fc\u30eb\u306e\u666e\u53ca\u304c\u55ab\u7dca\u306e\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u8fd1\u5e74\u3001\u81e8\u5e8a\u9769\u65b0\u3001\u30c7\u30b8\u30bf\u30eb\u5909\u9769\u3001\u60a3\u8005\u4e2d\u5fc3\u306e\u30b1\u30a2\u30e2\u30c7\u30eb\u304c\u878d\u5408\u3057\u3001\u5fc3\u8840\u7ba1\u8a3a\u65ad\u3001\u6cbb\u7642\u3001\u4e88\u9632\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u6295\u8cc7\u304c\u6d3b\u767a\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u898f\u5236\u5f53\u5c40\u306f\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30a8\u30d3\u30c7\u30f3\u30b9\u3068\u4fa1\u5024\u30d9\u30fc\u30b9\u306e\u511f\u9084\u3092\u91cd\u8996\u3057\u3001\u88fd\u9020\u696d\u8005\u306b\u306f\u88fd\u54c1\u306e\u6709\u52b9\u6027\u3068\u8cbb\u7528\u5bfe\u52b9\u679c\u3092\u793a\u3059\u5805\u7262\u306a\u81e8\u5e8a\u30c7\u30fc\u30bf\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u306e\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306f\u3001\u6280\u8853\u7684\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u3068\u30b1\u30a2\u30d1\u30e9\u30c0\u30a4\u30e0\u306e\u5909\u5316\u306b\u3088\u308a\u5927\u304d\u304f\u5909\u8c8c\u3057\u3066\u3044\u307e\u3059\u3002AI\u3092\u642d\u8f09\u3057\u305f\u30c7\u30b8\u30bf\u30eb\u753b\u50cf\u30b7\u30b9\u30c6\u30e0\u306f\u8a3a\u65ad\u7cbe\u5ea6\u3068\u52b9\u7387\u3092\u9ad8\u3081\u3001\u30af\u30e9\u30a6\u30c9\u63a5\u7d9a\u578b\u8840\u5727\u30e2\u30cb\u30bf\u30fc\u306f\u7d99\u7d9a\u7684\u306a\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002\u690d\u8fbc\u307f\u578b\u9664\u7d30\u52d5\u5668\u3084\u30da\u30fc\u30b9\u30e1\u30fc\u30ab\u30fc\u306a\u3069\u306e\u6cbb\u7642\u30c7\u30d0\u30a4\u30b9\u306f\u3001\u9ad8\u5ea6\u306a\u30c6\u30ec\u30e1\u30c8\u30ea\u30fc\u6a5f\u80fd\u3067\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u30c7\u30fc\u30bf\u3092\u63d0\u4f9b\u3057\u3001\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306a\u7ba1\u7406\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u696d\u754c\u306f\u4e88\u9632\u7684\u30fb\u30db\u30ea\u30b9\u30c6\u30a3\u30c3\u30af\u30b1\u30a2\u3078\u79fb\u884c\u3057\u3001\u88fd\u85ac\u4f1a\u793e\u306f\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u30e1\u30fc\u30ab\u30fc\u3068\u5354\u529b\u3057\u3066\u591a\u56e0\u5b50\u30ea\u30b9\u30af\u8981\u56e0\u306b\u5bfe\u51e6\u3059\u308b\u4f75\u7528\u7642\u6cd5\uff08\u30aa\u30e1\u30ac3\u3001\u690d\u7269\u30b9\u30c6\u30ed\u30fc\u30eb\u3001\u30b3\u30a8\u30f3\u30b6\u30a4\u30e0Q10\u306a\u3069\uff09\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u60a3\u8005\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u6559\u80b2\u3001\u670d\u85ac\u30ea\u30de\u30a4\u30f3\u30c0\u30fc\u3001\u9060\u9694\u8a3a\u7642\u3092\u7d71\u5408\u3057\u3001\u4fa1\u5024\u30d9\u30fc\u30b9\u306e\u30b1\u30a2\u30e2\u30c7\u30eb\u3092\u63a8\u9032\u3002\u898f\u5236\u5f53\u5c40\u3082\u753b\u671f\u7684\u306a\u30c7\u30d0\u30a4\u30b9\u3084\u30c7\u30b8\u30bf\u30eb\u6cbb\u7642\u85ac\u306e\u8fc5\u901f\u5be9\u67fb\u7d4c\u8def\u3092\u5c0e\u5165\u3057\u3001\u9ad8\u5f71\u97ff\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u5e02\u5834\u6295\u5165\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u306f\u3001\u5b66\u969b\u7684\u5354\u529b\u3001\u30c7\u30fc\u30bf\u99c6\u52d5\u578b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3001\u60a3\u8005\u4e2d\u5fc3\u306e\u7cbe\u795e\u304c\u672a\u6765\u3092\u5f62\u6210\u3059\u308b\u5909\u9769\u671f\u306b\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>**\u5e02\u5834\u63a8\u9032\u8981\u56e0**<\/p>\n<p>2025\u5e74\u306b\u5c0e\u5165\u3055\u308c\u305f\u95a2\u7a0e\u306f\u3001\u7c73\u56fd\u306b\u304a\u3051\u308b\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u88fd\u54c1\u306e\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3068\u4fa1\u683c\u8a2d\u5b9a\u306b\u8907\u96d1\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u8f38\u5165\u533b\u7642\u6a5f\u5668\u90e8\u54c1\u3001\u533b\u85ac\u54c1\u539f\u6750\u6599\u3001\u7279\u6b8a\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u3078\u306e\u8ab2\u5fb4\u91d1\u306f\u3001\u88fd\u9020\u696d\u8005\u306b\u8abf\u9054\u6226\u7565\u3068\u30b3\u30b9\u30c8\u69cb\u9020\u306e\u898b\u76f4\u3057\u3092\u4fc3\u3057\u3001\u56fd\u5185\u88fd\u9020\u80fd\u529b\u306e\u62e1\u5927\u3084\u4ee3\u66ff\u5730\u57df\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u6a21\u7d22\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u54c1\u8cea\u4fdd\u8a3c\u30d7\u30ed\u30c8\u30b3\u30eb\u306e\u5909\u66f4\u3084\u533b\u7642\u63d0\u4f9b\u8005\u306b\u304a\u3051\u308b\u53d6\u5f97\u30b3\u30b9\u30c8\u306e\u4e0a\u6607\u304c\u751f\u3058\u3066\u3044\u307e\u3059\u304c\u3001\u540c\u6642\u306b\u56fd\u5185\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306e\u5f37\u5316\u3068\u3001\u3088\u308a\u591a\u69d8\u3067\u56de\u5fa9\u529b\u306e\u3042\u308b\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u69cb\u7bc9\u306e\u6a5f\u4f1a\u3082\u751f\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5fc3\u8840\u7ba1\u30d8\u30eb\u30b9\u30b1\u30a2\u5e02\u5834\u306f\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u3001\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u3063\u3066\u591a\u89d2\u7684\u306b\u5206\u6790\u3055\u308c\u307e\u3059\u3002\u88fd\u54c1\u30bf\u30a4\u30d7\u3067\u306f\u3001\u8a3a\u65ad\u7528\u533b\u7642\u6a5f\u5668\uff08\u8840\u5727\u30e2\u30cb\u30bf\u30fc\u3001\u5fc3\u81d3\u753b\u50cf\u30b7\u30b9\u30c6\u30e0\u306a\u3069\uff09\u3068\u6cbb\u7642\u7528\u533b\u7642\u6a5f\u5668\uff08\u9664\u7d30\u52d5\u5668\u3001\u30da\u30fc\u30b9\u30e1\u30fc\u30ab\u30fc\u3001\u30b9\u30c6\u30f3\u30c8\u306a\u3069\uff09\u306b\u52a0\u3048\u3066\u3001\u533b\u85ac\u54c1\uff08\u6297\u51dd\u56fa\u5264\u3001\u964d\u5727\u5264\u3001\u30b9\u30bf\u30c1\u30f3\u3001\u8840\u7ba1\u62e1\u5f35\u5264\u306a\u3069\uff09\u3001\u305d\u3057\u3066\u88dc\u5b8c\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u3057\u3066\u306e\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\uff08\u30b3\u30a8\u30f3\u30b6\u30a4\u30e0Q10\u3001\u30aa\u30e1\u30ac3\u3001\u690d\u7269\u30b9\u30c6\u30ed\u30fc\u30eb\u306a\u3069\uff09\u306b\u5927\u5225\u3055\u308c\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/60882"}],"collection":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/comments?post=60882"}],"version-history":[{"count":2,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/60882\/revisions"}],"predecessor-version":[{"id":61830,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/60882\/revisions\/61830"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/media?parent=60882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/categories?post=60882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/tags?post=60882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}